Tyrosine kinase inhibitors are potent and selective inhibitors of UGT1A1: Tools for UGT phenotyping

被引：0
|
作者：
Kalyanaraman, Nataraj
Li, Chun
Surapaneni, Sekhar S.
Kumar, Gondi N.
机构：
[1] Amgen Inc, PKDM, Thousand Oaks, CA 91320 USA
[2] Amgen Inc, Dept PKDM MS, Newbury Pk, CA USA
[3] Amgen Inc, Dept PKDM MS, Thousand Oaks, CA 91320 USA
来源：
DRUG METABOLISM REVIEWS | 2006年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
74
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [1] In vitro UGT1A1 inhibition by tyrosine kinase inhibitors and association with drug-induced hyperbilirubinemia
    Qosa, Hisham
    Avaritt, Brittany R.
    Hartman, Neil R.
    Volpe, Donna A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (05) : 795 - 802
  • [2] In vitro UGT1A1 inhibition by tyrosine kinase inhibitors and association with drug-induced hyperbilirubinemia
    Hisham Qosa
    Brittany R. Avaritt
    Neil R. Hartman
    Donna A. Volpe
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 795 - 802
  • [3] UGT1A1 genotype does not affect tyrosine kinase inhibitors efficacy and safety in chronic myeloid leukemia
    Iurlo, Alessandra
    Bucelli, Cristina
    Cattaneo, Daniele
    Levati, Giorgia Virginia
    Viani, Benedetta
    Tavazzi, Dario
    Consonni, Dario
    Baldini, Luca
    Cappellini, Maria Domenica
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (11) : E283 - E285
  • [4] Recent progress and challenges in screening and characterization of UGT1A1 inhibitors
    Xia Lv
    Yangliu Xia
    Moshe Finel
    Jingjing Wu
    Guangbo Ge
    Ling Yang
    Acta Pharmaceutica Sinica B, 2019, 9 (02) : 258 - 278
  • [5] RECENT PROGRESS AND CHALLENGES IN SCREENING AND CHARACTERIZATION OF UGT1A1 INHIBITORS
    不详
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2020, 124 (04): : 549 - 549
  • [6] Recent progress and challenges in screening and characterization of UGT1A1 inhibitors
    Lv, Xia
    Xia, Yangliu
    Finel, Moshe
    Wu, Jingjing
    Ge, Guangbo
    Yang, Ling
    ACTA PHARMACEUTICA SINICA B, 2019, 9 (02) : 258 - 278
  • [7] Geno- and phenotyping of the UGT1A1 promotor polymorphism
    Zuehlsdorf, MT
    Rauchschwalbe, SK
    Schuehly, U
    Kuhlmann, J
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2000, 78 (07): : B53 - B53
  • [8] UGT1A1*6 and UGT1A1*27 for individualized irinotecan chemotherapy
    Ando, Yuichi
    Fujita, Ken-ichi
    Sasaki, Yasutsuna
    Hasegawa, Yoshinori
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2007, 9 (03) : 258 - 262
  • [9] UGT1A1 and UGT1A3 activity and inhibition in human liver and intestinal microsomes and a recombinant UGT system under similar assay conditions using selective substrates and inhibitors
    Mullapudi, T. V. Radhakrishna
    Ravi, Punna Rao
    Thipparapu, Ganapathi
    XENOBIOTICA, 2021, 51 (11) : 1236 - 1246
  • [10] Profiling of UGT1A1*6, UGT1A1*60, UGT1A1*93, and UGT1A1*28 Polymorphisms in Indonesian Neonates With Hyperbilirubinemia Using Multiplex PCR Sequencing
    Amandito, Radhian
    Rohsiswatmo, Rinawati
    Carolina, Erica
    Maulida, Rizka
    Kresnawati, Windhi
    Malik, Amarila
    FRONTIERS IN PEDIATRICS, 2019, 7
12345